Evaluation of AMG 714 for Vitiligo
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at UC Davis UC Irvine
- Dates
- study startedestimated completion
- Principal Investigator
- by Anand Ganesan, MD, PhD (uci)Victor Huang, MD (ucdavis)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at UC Health
- Anand Ganesan, MD, PhD (uci)
Professor, Dermatology. Authored (or co-authored) 32 research publications. - Victor Huang, MD (ucdavis)
Assistant Professor, Dermatology. Authored (or co-authored) 23 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Links
- Immune Tolerance Network (ITN) Division of Allergy, Immunology, and Transplantation (DAIT) National Institute of Allergy and Infectious Diseases (NIAID) NIH health information: Vitiligo
- ID
- NCT04338581
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated